Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good?
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- معلومة اضافية
- نبذة مختصرة :
This article discusses the relationship between atrial myopathy and heart failure with preserved ejection fraction (HFpEF). The left atrium (LA) is an important indicator of left ventricular (LV) function, and LA dilatation can indicate LV dysfunction, mitral valve disease, or atrial fibrillation. Atrial dilatation and dysfunction are common in older individuals and are associated with an increased risk of cardiovascular events. Diagnosing HFpEF can be challenging, but an echocardiogram can help identify the condition. The article suggests that the term "atrial myopathy" may not accurately reflect the underlying causes of atrial dysfunction and could potentially confuse readers. The authors emphasize the importance of precise diagnosis and management of HFpEF. [Extracted from the article]
No Comments.